X

About this post

Source
Author
Date
5:15 AM | February 20, 2013
Language
English
Categories
URL
Link to this page


Japanese scientists have recently announced that a small-scale human clinical trial for therapeutic application of induced pluripotent stem cells (iPSC) in the treatment of age-related macular degeneration (AMD) will take place at the Institute for Biomedical Research and Innovation, together with the RIKEN Center for Developmental Biology, in Kobe, Japan. The trial aims at generating retinal [...]The post First iPSC clinical trial approved appeared first on Oxbridge Biotech.

Tags

Comments

Log in to leave a comment